About the Webinar

Clinical development is the cornerstone of evaluating the safety and efficacy of novel therapeutics. The decisions made ultimately enhance patient outcomes and improve treatment standards across therapy areas.

Each study is meticulously planned, informed by extensive research, and guided by months of careful preparation, through to the involvement of volunteer participants.

Despite these efforts, the likelihood of success remains low, with approximately 92% of candidate drugs failing in clinical trials. However, this outlook is improving through the adoption of AI-driven simulations and opportunities to optimize trial design that this technology provides.

By harnessing billions of data points from previous trials, AI clinical trial simulation is being leveraged, ultimately increasing the probability of technical success through improved planning.

Clinical development has long set the gold standard for data generation. Now, for the first time, the wealth of this historical data can be systematically leveraged to better inform, guide, and accelerate future trials.

Join Adam Petrich, MD, (Chief Medical Officer of QuantHealth), for this 30-minute event, sharing the latest on how Clinical Development professionals’ usage of AI is already having a profound impact on drug development.

Agenda

● Explore the impact of AI-driven simulation on clinical development strategies and outcomes.
● Understand how historical real-world data and proprietary biomedical knowledge graphs can optimize future trial design and decision-making.
● Discover tactics to increase clinical trial success rates and accelerate drug development progress.